Niclosamide–Clay Intercalate Coated with Nonionic Polymer for Enhanced Bioavailability toward COVID-19 Treatment
Niclosamide (NIC), a conventional anthelmintic agent, is emerging as a repurposed drug for COVID-19 treatment. However, the clinical efficacy is very limited due to its low oral bioavailability resulting from its poor aqueous solubility. In the present study, a new hybrid drug delivery system made o...
Main Authors: | Seungjin Yu, Huiyan Piao, N. Sanoj Rejinold, Geunwoo Jin, Goeun Choi, Jin-Ho Choy |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2021-03-01
|
Series: | Polymers |
Subjects: | |
Online Access: | https://www.mdpi.com/2073-4360/13/7/1044 |
Similar Items
-
Bovine Serum Albumin-Coated Niclosamide-Zein Nanoparticles as Potential Injectable Medicine against COVID-19
by: Sanoj Rejinold N, et al.
Published: (2021-07-01) -
Hydrotalcite–Niclosamide Nanohybrid as Oral Formulation towards SARS-CoV-2 Viral Infections
by: Goeun Choi, et al.
Published: (2021-05-01) -
Pharmaceutical particle technologies: An approach to improve drug solubility, dissolution and bioavailability
by: Prakash Khadka, et al.
Published: (2014-12-01) -
Nanocrystals for enhancement of oral bioavailability of poorly water-soluble drugs
by: Varaporn Buraphacheep Junyaprasert, et al.
Published: (2015-02-01) -
Pharmacokinetic considerations for enhancing drug repurposing opportunities of anthelmintics: Niclosamide as a case study
by: Jeong In Seo, et al.
Published: (2024-04-01)